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Summary the epithelial hemidesmosomes in the skin, the mucous
membranes, and the eye (Nishizawa et al. 1993). TheJunctional epidermolysis bullosa (JEB) is a clinically and
cDNA structure predicts an unusual type II integralbiologically heterogeneous genodermatosis, character-
transmembrane molecule with several protein kinaseized by trauma-induced blistering and healing without
consensus sequences in its cytoplasmic domain and withscarring but sometimes with skin atrophy. We investi-
a large extracellular collagenous domain (Giudice et al.gated three unrelated patients with different JEB pheno-
1992), but the protein structure has not yet been fullytypes. Patients 1 and 2 had generalized atrophic benign
characterized (Hirako et al. 1996). Because of the colla-epidermolysis bullosa (GABEB), with features including
genous sequences in the ectodomain, the molecule hasskin atrophy and alopecia. Patient 3 had the localisata
been designated ‘‘collagen XVII,’’ a member of the colla-variant of JEB, with predominantly acral blistering and
gen protein family (Li et al. 1993; Gatalica et al. 1997).normal hair. All patients carried novel homozygous
As a transmembrane component of the hemidesmo-point mutations (Q1016X, R1226X, and R1303Q) in
somes, collagen XVII presumably plays a role in main-the COL17A1 gene encoding collagen XVII, a hemides-
taining the linkage and integrity between the intracellu-mosomal transmembrane component; and, therefore,
lar and the extracellular hemidesmosome componentsnot only GABEB but also the localisata JEB can be a
and in anchoring the epithelial cells to the underlyingcollagen XVII disorder. The nonsense mutations led to
basement membrane (Hopkinson et al. 1995). This con-drastically reduced collagen XVII mRNA and protein
cept is evidenced indirectly by several pathological con-levels. In contrast, the missense mutation allowed ex-
ditions. For example, in bullous autoimmune diseases,pression of abnormal collagen XVII, and epidermal ex-
such as bullous pemphigoid, cicatricial pemphigoid, andtracts from that patient contained polypeptides of nor-
herpes gestationes, the presence of autoantibodies reac-mal size, as well as larger aggregates. The homozygous
tive with collagen XVII is associated with diminishednonsense mutations in the COL17A1 gene were consis-
epidermal/dermal cohesion (Ishiko et al. 1993; Liu et al.tent with the absence of the collagen from the skin and
1993; Giudice et al. 1994; Balding et al. 1996). Further-with the GABEB phenotype, whereas homozygosity for
more, a hereditary blistering disorder of the skin, thethe missense mutation resulted in expression of aberrant
generalized atrophic benign epidermolysis bullosacollagen XVII and, clinically, in localisata JEB.
(GABEB), is associated with absence or altered expres-
sion of collagen XVII (Jonkman et al. 1995, 1996).
Introduction Junctional epidermolysis bullosa (JEB) refers to a
group of genetic blistering diseases with characteristicCollagen XVII, also known as the 180-kD bullous pem-
features of skin fragility, ultrastructurally rudimentaryphigoid antigen, or BP180, is a structural component of
hemidesmosomes, and separation of the basal keratino-
cytes from the basement membrane. JEB contains several
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tends to become atrophic and fragile at sites of repeated
blistering.
GABEB is characterized by generalized blistering and
skin atrophy; alopecia of the scalp; partial absence of
eyelashes, eyebrows, and pubic and axillary hair; nail
dystrophy; and tooth anomalies (Hashimoto et al. 1976;
Hintner and Wolff 1982). Recently, the ﬁrst mutations
in the gene encoding collagen XVII were determined in
GABEB families (McGrath et al. 1995). Most of the
mutations reported thus far (McGrath et al. 1995,
1996a; Darling et al. 1997; Gatalica et al. 1997) have
been homozygous or heterozygous mutations leading to
premature termination codons (PTC) and, in one case,
to a missense glycine-substitution mutation (McGrath
et al. 1996b). Because of the limited number of muta-
tions, little is known about the genotype-phenotype cor-
relations in these patients.
In the present study, we have identiﬁed three homozy-
gous point mutations in the COL17A1 gene. Two of
these resulted in PTC and, clinically, in the GABEB phe-
notype. The third was a missense mutation that led to
expression of aberrant collagen XVII and to a partial
loss of function of this protein, accompanying a clini-
cally milder localisata JEB phenotype.
Figure 1 Clinical features of patient 1, with the GABEB pheno-Patients, Material, and Methods
type, and patient 3, with the localisata phenotype. A, Generalized
small blisters and typical parietal alopecia in patient 1. B, NormalPatients
hair of patient 3. C, Localized blistering and skin atrophy of the left
Patient 1.—The proband, an 18-year-old female, is the hand of patient 3. D, Skin atrophy and nail dystrophy of the feet of
only child of healthy parents, and her clinical features at patient 3.
a young age were described by Zortea-Caﬂisch (1985).
There was no family history of related skin diseases or
similar genetic disorders. There was no known history but with skin atrophy. Blistering of the scalp led to dif-
of consanguineity, but both parents originated from the fuse alopecia. Electron microscopy showed junctional
same region in the central European Alps. The proband blistering and severely hypoplastic hemidesmosomes in
presented at birth with multiple blisters of the arms and the basal keratinocytes at the blister roof.
legs. Mechanically induced and spontaneous blisters Patient 3.—The proband, a 53-year-old male, is the
continued to appear, the extremities, head, and face be- only offspring of a consanguineous marriage, his parents
ing most often affected. The blisters healed without scars being third cousins. The proband has a clinically unaf-
but with some atrophy and hyperpigmentation. Periun- fected daughter. The family history was negative for
gual blistering and paronychia led to dystrophy of all skin diseases or genetic disorders. The proband had had
nails. Beginning at the age of 6 years, patchy alopecia trauma-induced blistering of the skin since school age
of the scalp developed, leading to loss of all parietal hair but developed an overall milder phenotype, with blis-
(ﬁg. 1A). The oral mucosa and the tongue were regularly tering predominantly at the distal extremities and, occa-
involved with erosions. This is the characteristic pheno- sionally, of the oral mucosa. During the course of the
type of GABEB. Electron microscopy showed junctional disease, all nails were lost, and mild skin atrophy devel-
blistering and hypoplastic hemidesmosomes (Zortea- oped on the extremities. He had slight alopecia of andro-
Caﬂisch 1985). genetic pattern (ﬁg. 1B–D). Electron microscopy
Patient 2.—The proband, a 9-year-old female, is the showed slight structural alterations of the hemidesmo-
older of two daughters of nonconsanguineous German somes (not shown).
parents. No other family member had a related skin
Informed Consentdisorder or a genodermatosis. She has had blistering of
the skin and the mucous membranes since birth. Me- Informed consent was obtained from all patients and
their relatives before biopsies or blood samples werechanically induced blisters often were localized to the
extremities and the face. They healed without scarring taken.
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Mutation Detection eraldehyde phosphate dehydrogenase was used as a ref-
erence probe to correct for small differences in RNAGenomic DNA was isolated from peripheral blood by
loading. The radioactive cDNA-mRNA hybrids wereuse of the Easy-DNATM kit according to the manufactur-
visualized by autoradiography by exposure of the ﬁlterser’s instructions (Invitrogen). Ampliﬁcation of exons 45,
to x-ray ﬁlms (X-Omat; Eastman Kodak).51, and 52 of COL17A1 was performed by use of prim-
ers placed on the ﬂanking intronic sequences (Giudice Keratinocyte Cultures
et al. 1992; Gatalica et al. 1997) (Genbank accession
Keratinocytes were obtained by trypsinization of con-M91669). Primers used for ampliﬁcation of exon 45
trol and JEB skin biopsies and were cultured in serum-were sense primer 5-CTCAGACCATGGAAGCTATT-
3 and antisense primer 5-CTTGGCAAAGAGACT-
GTATC-3. The size of the PCR product was 272 bp.
Primers used for ampliﬁcation of exon 51 were sense
primer 5-TTTCTCTCCTCCCATCACCC-3 and anti-
sense primer 5-TGTCCCTTTAAGTGCCTCCC-3.
The size of the ampliﬁcation product was 374 bp. Prim-
ers used for ampliﬁcation of exon 52 were sense primer
5-CAAGTCTTTCTCTCCACCGA-3 and antisense
primer 5-CCACAAACAAGAAAGCCAGT-3. The size
of the ampliﬁcation product was 526 bp. PCR was per-
formed under standard conditions (Christiano et al.
1994), and heteroduplex analysis was performed as de-
scribed elsewhere (Ganguly et al. 1993; Gatalica et al.
1997). If a heteroduplex band was detected, the PCR
products were puriﬁed with a PCR puriﬁcation kit
according to the manufacturer’s recommendations
(QIAGEN), followed by sequencing by an automated
sequencer (Applied Biosystems).
A Novel Polymorphic Site in the COL17A1 Gene
AG/A sequence variation at position 2212 of the cDNA
within exon 27 was detected in DNA samples of unaf-
fected individuals. PCR products spanning exon 27 and
ﬂanking intronic sequences were made by use of sense
primer 5-TGAGGGTCTGATGGACACGA-3 and anti-
sense primer 5-TCTTGGTCCAGGTCCTGTGC-3. The
size of the PCR product was 306 bp. The BsrI restriction
enzyme (NCCAGT) was used according to the manufac-
turer’s (New England Biolabs) recommendations. In the
case of homozygosity for the base G at position 2212
of the cDNA , the PCR product was cut into 173-bp
Figure 2 IF staining of the patients’ and control skin with anti-and 133-bp fragments. In case of homozygosity for the
body 1D1 to the extracellular domain of collagen XVII (A, C, E, andbase A, a single 306-bp fragment remained undigested,
G) and, as a control, to collagen VII (B, D, F, and H). Staining with
indicating absence of the BsrI site. The allele frequencies antibodies to collagen XVII showed lack of reaction in the skin of
in 80 chromosomes were 78% G and 22% A; the PIC patient 1 (A). In the skin of patient 2, the epidermis was detached,
but the basement membrane of the sweat glands demonstrated lackvalue was .28.
of reactivity with the collagen XVII antibody (C). In the skin of patient
3, staining with antibodies to collagen XVII was positive and localizedNorthern Blotting
to the blister roof at separated areas (E). In panel G, control staining
Total RNA was isolated from cultured JEB and con- of normal skin with antibodies to collagen XVII is shown. IF staining
trol keratinocytes by use of the guanidine isothiocyanate of the biopsies with the antibody 1A8C to the intracellular domain
of collagen XVII exhibited the same staining pattern as above (notmethod (Chromczynski and Sacchi 1987). For northern
shown); in comparison, staining with antibodies to collagen VII, an-blotting, the RNA was separated on formaldehyde-con-
other component of the anchoring complex, was positive in all biopsiestaining agarose gels (Sambrook et al. 1990) and then
(B, patient 1; D, patient 2; F, patient 3; and H, normal control). The
was vacuum transferred onto a nitrocellulose ﬁlter and staining was localized to the blister ﬂoor in patients 1 and 3, conﬁrm-
hybridized with a 32P-dCTP- and 32P-dGTP-radiolabeled ing junctional blistering. The arrowheads point to the blister roof (in
panels B and F) and to the blister ﬂoor (in panel E).COL17A1 cDNA (McGrath et al. 1995). cDNA of glyc-
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free keratinocyte growth medium containing 0.09 mM following antibodies were employed: cytokeratins (Dako),
BP230 (a high-titer autoantiserum), a6 and b4 integrinscalcium supplemented with bovine pituitary extract and
(Gibco Life Technologies), collagen IV (Dako), laminin 5epidermal growth factor (KGMTM; Gibco), as described
(monoclonal antibody BM-165, a kind gift from Dr. R.elsewhere (Ko¨nig and Bruckner-Tuderman 1992).
Burgeson, CBRC, Harvard Medical School, Cambridge,
Antibodies and Immunodetection of Proteins MA), and polyclonal antibodies against collagen VII
The monoclonal antibodies 1A8C and 1D1, recognizing (Bruckner-Tuderman et al. 1995). Immunoﬂuorescence
the intra- and extracellular domains of collagen XVII, re- (IF) staining of cryosections of skin or of cultured keratino-
spectively, were produced and characterized as described cytes was performed with standard techniques, by use of
elsewhere (Kitajima et al. 1992; Nishizawa et al. 1993). either ﬂuorescein isothiocyanate (FITC)–labeled second
Autoantisera from patients with cicatricial pemphigoid antibodies (Dako) or ampliﬁcation with biotin-labeled sec-
that were strongly reactive with collagen XVII were used ond antibodies and FITC-streptavidin (Boehringer-Mann-
for immunoblotting (Schumann and Bruckner-Tuderman heim). Immunoblotting of keratinocyte and epidermal ex-
tracts was performed essentially as described elsewhere1996). For antigen mapping (Hintner et al. 1981), the
Figure 3 Mutations in the COL17A1 gene in patient 1 and the parents. A, Conformation-sensitive gel electrophoresis (CSGE) analysis
of the PCR product containing exon 45, which revealed heteroduplex bands in both parents’ DNA (lanes 1 and 3) and in the proband’s DNA,
when mixed with the same PCR product from an unrelated control individual (lane 4). The proband’s DNA (lane 2) and control DNA (lane
5) showed homoduplex bands when tested alone. B, Automated sequence analysis of the patient’s DNA, which revealed a homozygous CrT
transition at nucleotide position 3151 of the cDNA, designated ‘‘Q1016X’’ (middle panel). The mutation was present in the heterozygous state
in the parents (lower panel) but was absent from a control (upper panel). C, Mutation as veriﬁed with allele-speciﬁc–oligonucleotide hybridiza-
tion, as described elsewhere (Christiano et al. 1994). Hybridization with oligonucleotides with the wild-type sequence (upper panel) showed a
strong signal with a control DNA (lane 5) and a weaker signal with DNA of both heterozygous parents (lanes 1 and 3). No signal was detectable
with the patient’s DNA (lane 2). Hybridization with the mutated sequence revealed a strong signal with the patient’s DNA (lane 2), a weaker
signal with the parents’ DNA (lanes 1 and 3), and no signal with control DNA (lane 5).
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Figure 4 Mutations in the COL17A1 gene in patient 2 and parents. A, CSGE analysis of the PCR product containing exon 51, which
revealed heteroduplex bands in both parents (lanes 1 and 2) and in the proband’s DNA, when mixed with the same PCR product from an
unrelated control individual (lane 4). The proband’s DNA (lane 3) and control DNA (lane 5) showed homoduplex bands when tested alone.
B, Automated sequencing disclosing a homozygous CrT transition in the proband, at nucleotide position 3781 of the cDNA, designated
‘‘R1226X’’ (middle panel). The mutation was present in the heterozygous state in the parents (lower panel) but was absent from the control
(upper panel). C, Mutation leading to loss of a TaqI restriction-enzyme site. The control PCR product (lane 5) was digested to 185-bp and
157-bp bands, whereas in both heterozygous parents (lanes 1 and 2) the mutation resulted in an additional, uncleaved 342-bp band. The
homozygous patient showed only the uncleaved 342-bp band (lane 3).
(Ko¨nig and Bruckner-Tuderman 1992; Bruckner-Tuder- three patients, the antibodies to cytokeratins, BP230, and
a6 and b4 integrins stained the blister roof, and the anti-man et al. 1995), with minor modiﬁcations (Sonnenberg
et al. 1991). bodies to laminin 5, collagen IV, and collagen VII stained
the blister ﬂoor. This staining pattern therefore conﬁrmed
junctional tissue separation in all three patients.Results
Immunohistological Phenotypes Identiﬁcation and Veriﬁcation of Mutations
Stainingwith antibody 1A8C to the intracellular domain On the basis of sequence information on the COL17A1
intron-exon organization (Gatalica et al. 1997), balancedand with antibody 1D1 to the extracellular domain of
collagen XVII revealed that the skin of patient 1 was nega- primer pairs were designed to allow PCR ampliﬁcation of
exons directly from genomic DNA. The primers weretive for most of the basement-membrane zone (ﬁg. 2A),
interrupted by a few short stretches of positive yet attenu- placed §24 bp away from the intron-exon borders. In
family 1, exon 45 was affected; in family 2, exon 51; and,ated staining. The skin of patient 2 was completely nega-
tive (ﬁg. 2C), whereas the skin of patient 3 was positive in family 3, exon 52. After mixing patients’ DNA with
control DNA, a heteroduplex band similar to that of carri-(ﬁg. 2E). In spontaneously blistered areas of skin from all
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Figure 5 Mutations in the COL17A1 gene in patient 3 and his daughter. A, CSGE analysis of the PCR product containing exon 52,
showing heteroduplex bands in the daughter (lane 3) and in the proband’s DNA, when mixed with the same PCR product from an unrelated
control individual (lane 4). The proband’s DNA (lane 2), as well as the DNA of his wife (lane 1) and of an unrelated control (lane C), showed
homoduplex bands when tested alone. B, Homozygous GrA transition at nucleotide position 4013 of the cDNA, designated ‘‘R1303Q,’’
disclosed by automated sequence analysis in the proband (middle panel). The mutation was present in the heterozygous state in the daughter
(lower panel) but was absent from the control (upper panel). C, Mutation that abolished an AciI restriction-enzyme site. The control’s and the
unaffected wife’s PCR products (lanes C and 1) were digested to 165-bp, 106-bp, 69-bp, 65-bp, and 59-bp fragments. The proband’s DNA
showed an additional 134-bp band and the loss of the 69-bp and 65-bp bands (lane 2). The heterozygous daughter (lane 3) had both the 134-
bp and the 69-bp and 65-bp bands.
ers was detected (ﬁgs. 3–5). This electrophoretic pattern blot analysis, a strong signal of collagen XVII mRNA
was found with control keratinocytes. Collagen XVIIindicated heterozygosity of the parents of patients 1 and
2 and of the daughter of patient 3, as well as homozygosity mRNA isolated from the JEB keratinocytes produced a
very weak signal, suggesting nonsense-mediated mRNAfor all three patients. Patient 1 was homozygous for a
3151CrT transition (Q1016X), and the parents were het- decay in these cells (ﬁg. 6).
erozygous (ﬁg. 3). Patient 2 was homozygous for a
Synthesis of Collagen XVII in Vitro3781CrT transition (R1226X), and each parent was het-
IF staining of keratinocytes of patient 1 with the anti-erozygous (ﬁg. 4). Patient 3 was homozygous for a
body 1A8C revealed a positive, diffuse intracellular IF4013GrA transition, and his daughter was heterozygous
indicating synthesis and intracellular accumulation of(ﬁg. 5).
immunoreactive protein fragments (ﬁg. 7). In contrast,
Expression of COL17A1 mRNA in control keratinocytes the positive reaction was ob-
served as a perinuclear ring corresponding to the roughTotal cellular RNA was isolated from cultivated kera-
tinocytes of controls and patients 1 and 2. In northern endoplasmatic reticulum and, in the cell periphery, to
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Figure 8 Immunoblotting of keratinocyte and epidermis ex-
tracts. Keratinocyte extracts of patients 1 (Pat 1) and 2 (Pat 2) were
Figure 6 Northern blotting of mRNA isolated from GABEB blotted with polyclonal antibodies to collagen XVII. Compared with
keratinocytes. A strong signal of collagen XVII mRNA was found control extracts (lanes 1 and 4, in both panels), the 180-kD collagen
with control keratinocytes (lanes 1 and 4); in contrast, collagen XVII XVII band was not detectable in the patients’ cells (lanes 2 and 3, in
mRNA isolated from keratinocytes of patients 1 (lane 3) and 2 (lane both panels). Since keratinocytes were not available from patient 3,
2) produced a very weak signal, suggesting nonsense-mediated mRNA epidermis extract was immunoblotted (Pat 3). The extract contained
decay in these cells. The intensity of the GAPDH signal was similar immunopositive collagen XVII polypeptides. In lane 1, normal epider-
in all lanes. mis extract containing the 180-kD a1(XVII) chain is shown. In addi-
tion, a second immunoreactive, diffuse band of Ç65 kD was observed
occasionally. The identity of this band has not been characterized. In
lane 2, the epidermis extract of patient 3 containing the normal 180-
the transmembrane location of collagen XVII (ﬁg. 7). kD a1(XVII) chain and an additional large molecular-weight band of
Ç300 kD (arrowhead), which was not present in normal epidermis,Staining with the antibody 1D1 showed a barely visible
is shown; also in the patient’s epidermis extract, the 65-kD band wasﬂuorescence in the patient’s keratinocytes but a positive
present. In lane 3, control keratinocyte extract is shown. The migrationmembrane-associated staining in control cells. Results positions of molecular-weight standards are indicated next to each
blot. The molecular weights are, from top to bottom, 205 kD, 116
kD, 82 kD, and 46 kD.
of staining of keratinocytes of patient 2 with either anti-
body were similar to those for negative controls, sug-
gesting either that the cells did not synthesize immunore-
active collagen XVII or that the nascent truncated
polypeptide chains were subjected to intracellular degra-
dation (ﬁg. 7). Keratinocyte cultures could not be initi-
ated from the skin biopsies of patient 3.
Immunoblotting conﬁrmed the results of the IF stain-
ing of keratinocytes of patients 1 and 2. The cells were
cultured in the presence of ascorbic acid, were extracted
with nonionic detergents, and were immunoblotted by
use of polyclonal antibodies against collagen XVII. A
single 180-kD band representing the a1(XVII) polypep-
Figure 7 IF staining of GABEB keratinocytes with domain-spe- tide chain of collagen XVII was found in control ex-
ciﬁc antibodies to collagen XVII. In control cells, the antibody 1D1
tracts, but with JEB extracts neither a1(XVII) polypep-to the extracellular domain showed a positive IF in the cell periphery,
tides nor any distinct fragments were demonstratablecorresponding to the transmembrane localization (A), and the anti-
body 1A8C to the intracellular domain showed a strongly positive (ﬁg. 8). In contrast, epidermal extracts of patient 3 re-
intracellular IF (D). The antibody 1D1 produced a barely visible stain- vealed immunoreactive collagen XVII in immunoblots.
ing in the keratinocytes of patient 1 (B) and no reaction with cells of The normal size a1(XVII) polypeptide chains were de-
patient 2 (C). Staining of keratinocytes of patient 1 with the antibody
tected, together with a larger immunoreactive band of1A8C (E) revealed a weak, diffuse intracellular IF. The staining, with
an apparent molecular weight close to 300 kD (ﬁg. 8).the latter antibody, of keratinocytes of patient 2 (F) was comparable
to that of the negative control. In extracts of normal epidermis, the larger band was
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cated collagen XVII cDNAs have implicated molecular
interactions with a6 integrin (Hopkinson et al. 1995).
Indirect demonstration of collagen XVII’s role in epider-
mal adhesion has been provided by its deﬁcient expres-
sion in GABEB patients (Jonkman et al. 1995, 1996).
Subsequently, homozygous or compound-heterozygous
nonsense mutations in the COL17A1 gene have been
disclosed in seven GABEB families (McGrath et al. 1995,
1996a; Darling et al. 1997; Gatalica et al. 1997). A
glycine-substitution mutation in combination with a
PTC was found in one patient with a phenotype some-
what different from classical GABEB (McGrath et al.
1996b).
In the present study, we describe three homozygous
COL17A1 mutations in unrelated central European JEB
patients. One of them, R1226X, previously had been
found in heterozygous form in a GABEB patient
(McGrath et al. 1995). The authors of that study did
not deﬁne the genealogical origin of their proband, and
therefore it remains unclear whether the mutation has
Figure 9 Electron microscopy of clinically uninvolved skin of a common founder or represents a mutational hot spot,
patient 1. Ultrastructural analysis showed rudimentary, narrow
similar to that in the LAMB3 gene associated with JEBhemidesmosomes (arrowheads), with lack of distinct dense plates.
Herlitz (Kivirikko et al. 1996; Pulkkinen et al. 1996).Other basement-membrane structures appeared normal.
The nonsense mutations described here resulted in
lack of collagen XVII from the skin; however, at the
cellular level, the phenotypes differed. Immunoreactivenot seen. In both normal and JEB epidermis extracts, a
collagen XVII epitopes were observed in keratinocytesdiffuse Ç65-kD band occasionally was seen. The band
of patient 1 but not in those of patient 2. The mutationis likely to represent an unspeciﬁc reaction, but the iden-
Q1016X is located in a noncollagenous domain,tity of the band has not been characterized.
whereas R1226X is in a collagenous domain (ﬁg. 10).
It is feasible that, in spite of nonsense-mediated mRNAElectron Microscopy
Ultrastructural analysis of a biopsy obtained from
clinically uninvolved skin of the upper thigh of patient 1
showed abnormal hemidesmosomes, with rudimentary
structure and lack of a distinct dense plate (ﬁg. 9). Other
basement-membrane structures, the lamina lucida, lam-
ina densa, anchoring ﬁlaments, and anchoring ﬁbrils ap-
peared normal. No dermal/epidermal separation was
observed in the sample. A fresh biopsy from patients 2
and 3 was not available for electon-microscopic exami-
nation.
Discussion
Collagen XVII presumably functions as both a struc-
Figure 10 Schematic representation of the predicted structuretural macromolecule and a cell-adhesion receptor. Its
of collagen XVII. The cDNA sequence (Giudice et al. 1992) predictscDNA structure predicts a transmembrane protein in
a type II transmembrane protein, with an amino-terminal intracellular
type II orientation, with an intracellular N-terminus and domain of 466 amino acid residues in length, a 22-amino-acid-long
an extracellular C-terminus containing an interrupted transmembrane domain, and a carboxy-terminal, rodlike collagenous
extracellular domain of 1,009 amino acids in length. The intracellularcollagenous domain (ﬁg. 10). Probably because of the
domain contains a cluster of cysteins and several protein kinase con-inaccessibility of the protein to standard biochemical
sensus sequences, and the ectodomain contains a repetitive collagenousanalyses, its molecular structure and functions have not
–Gly–X–Y– sequence with multiple interruptions. The solid black
been investigated in detail. Nevertheless, cross-linking line indicates noncollagenous sequences, and the open boxes indicate
experiments have suggested a trimeric structure (Hirako collagenous sequences. The localization of the mutations and the poly-
morphic site in the present study are indicated by arrows.et al. 1996), and transfection experiments with trun-
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and Marcel Jonkman for helpful discussions. This investiga-decay, small amounts of nascent truncated polypeptide
tion was supported by grants Br 1475/1-1, Br 1475/2-1, andchains are synthesized and accumulate intracellularly
SFB 293 Mu¨nster/B3, all to L.B.-T., from the Deutscheprior to degradation through default pathways. Muta-
Forschungsgemeinschaft and by U.S. Public Health Servicetions in the noncollagenous domains may yield more
NIH grant P01-AR38923 to J.U. H.S. was fellow of thestable mutant polypeptides than are produced by those
Deutscher Akademischer Austauschdienst, and L.P. was sup-
in the collagenous domains. ported by the Dermatology Foundation.
Interestingly, the missense mutation R1303Q led to a
different biological and clinical phenotype, the localisata
variant of JEB. This observation indicates that collagen References
XVII mutations underlie not only GABEB but other junc-
Balding SD, Prost C, Diaz LA, Bernard P, Bedane C, Aberdamtional EB subtypes as well. Collagen XVII was present at
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